Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Somatic cell nuclear transfer in non-enucleated goldfish oocytes: understanding DNA fate during oocyte activation and first cellular division.

Rouillon C, Depincé A, Chênais N, Le Bail PY, Labbé C.

Sci Rep. 2019 Aug 28;9(1):12462. doi: 10.1038/s41598-019-48096-2.

2.

A Type III CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator.

Athukoralage JS, Graham S, Grüschow S, Rouillon C, White MF.

J Mol Biol. 2019 Jul 12;431(15):2894-2899. doi: 10.1016/j.jmb.2019.04.041. Epub 2019 May 6.

3.

Investigation of the cyclic oligoadenylate signaling pathway of type III CRISPR systems.

Rouillon C, Athukoralage JS, Graham S, Grüschow S, White MF.

Methods Enzymol. 2019;616:191-218. doi: 10.1016/bs.mie.2018.10.020. Epub 2019 Jan 12.

PMID:
30691643
4.

Ring nucleases deactivate type III CRISPR ribonucleases by degrading cyclic oligoadenylate.

Athukoralage JS, Rouillon C, Graham S, Grüschow S, White MF.

Nature. 2018 Oct;562(7726):277-280. doi: 10.1038/s41586-018-0557-5. Epub 2018 Sep 19.

5.

Control of cyclic oligoadenylate synthesis in a type III CRISPR system.

Rouillon C, Athukoralage JS, Graham S, Grüschow S, White MF.

Elife. 2018 Jul 2;7. pii: e36734. doi: 10.7554/eLife.36734.

6.

Primed CRISPR adaptation in Escherichia coli cells does not depend on conformational changes in the Cascade effector complex detected in Vitro.

Krivoy A, Rutkauskas M, Kuznedelov K, Musharova O, Rouillon C, Severinov K, Seidel R.

Nucleic Acids Res. 2018 May 4;46(8):4087-4098. doi: 10.1093/nar/gky219.

7.

NMR assignment and solution structure of the external DII domain of the yeast Rvb2 protein.

Bragantini B, Rouillon C, Charpentier B, Manival X, Quinternet M.

Biomol NMR Assign. 2018 Oct;12(2):243-247. doi: 10.1007/s12104-018-9816-5. Epub 2018 Mar 22.

PMID:
29569106
8.

Prespacer processing and specific integration in a Type I-A CRISPR system.

Rollie C, Graham S, Rouillon C, White MF.

Nucleic Acids Res. 2018 Feb 16;46(3):1007-1020. doi: 10.1093/nar/gkx1232.

9.

Real versus sham proximal biofield therapy in the treatment of warts of the hands and feet in adults: study protocol for a randomized controlled trial (MAGNETIK study).

Gaillard C, Allain L, Legros H, Brucato S, Desgue Y, Rouillon C, Peyro-Saint-Paul L, Dompmartin A.

Trials. 2017 Jun 7;18(1):263. doi: 10.1186/s13063-017-1994-4.

10.

Single-Molecule Insight Into Target Recognition by CRISPR-Cas Complexes.

Rutkauskas M, Krivoy A, Szczelkun MD, Rouillon C, Seidel R.

Methods Enzymol. 2017;582:239-273. doi: 10.1016/bs.mie.2016.10.001. Epub 2016 Dec 5.

PMID:
28062037
11.

Structure of the CRISPR interference complex CSM reveals key similarities with cascade.

Rouillon C, Zhou M, Zhang J, Politis A, Beilsten-Edmands V, Cannone G, Graham S, Robinson CV, Spagnolo L, White MF.

Mol Cell. 2013 Oct 10;52(1):124-34. doi: 10.1016/j.molcel.2013.08.020.

12.

Protein-induced changes in DNA structure and dynamics observed with noncovalent site-directed spin labeling and PELDOR.

Reginsson GW, Shelke SA, Rouillon C, White MF, Sigurdsson ST, Schiemann O.

Nucleic Acids Res. 2013 Jan 7;41(1):e11. doi: 10.1093/nar/gks817. Epub 2012 Aug 31.

13.

Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity.

Zhang J, Rouillon C, Kerou M, Reeks J, Brugger K, Graham S, Reimann J, Cannone G, Liu H, Albers SV, Naismith JH, Spagnolo L, White MF.

Mol Cell. 2012 Feb 10;45(3):303-13. doi: 10.1016/j.molcel.2011.12.013. Epub 2012 Jan 5.

14.

Staphylococcus aureus DinG, a helicase that has evolved into a nuclease.

McRobbie AM, Meyer B, Rouillon C, Petrovic-Stojanovska B, Liu H, White MF.

Biochem J. 2012 Feb 15;442(1):77-84. doi: 10.1042/BJ20111903.

15.

The evolution and mechanisms of nucleotide excision repair proteins.

Rouillon C, White MF.

Res Microbiol. 2011 Jan;162(1):19-26. doi: 10.1016/j.resmic.2010.09.003. Epub 2010 Sep 21. Review.

PMID:
20863882
16.

The XBP-Bax1 helicase-nuclease complex unwinds and cleaves DNA: implications for eukaryal and archaeal nucleotide excision repair.

Rouillon C, White MF.

J Biol Chem. 2010 Apr 2;285(14):11013-22. doi: 10.1074/jbc.M109.094763. Epub 2010 Feb 6.

17.

The helicase XPD unwinds bubble structures and is not stalled by DNA lesions removed by the nucleotide excision repair pathway.

Rudolf J, Rouillon C, Schwarz-Linek U, White MF.

Nucleic Acids Res. 2010 Jan;38(3):931-41. doi: 10.1093/nar/gkp1058. Epub 2009 Nov 20.

18.

Risk factors for upper-extremity musculoskeletal disorders in the working population.

Roquelaure Y, Ha C, Rouillon C, Fouquet N, Leclerc A, Descatha A, Touranchet A, Goldberg M, Imbernon E; Members of Occupational Health Services of the Pays de la Loire Region.

Arthritis Rheum. 2009 Oct 15;61(10):1425-34. doi: 10.1002/art.24740.

19.

Binding to PCNA in Euryarchaeal DNA Replication requires two PIP motifs for DNA polymerase D and one PIP motif for DNA polymerase B.

Castrec B, Rouillon C, Henneke G, Flament D, Querellou J, Raffin JP.

J Mol Biol. 2009 Nov 27;394(2):209-18. doi: 10.1016/j.jmb.2009.09.044. Epub 2009 Sep 23.

PMID:
19781553
20.

Neuroprotection by nitrous oxide: facts and evidence.

Haelewyn B, David HN, Rouillon C, Chazalviel L, Lecocq M, Risso JJ, Lemaire M, Abraini JH.

Crit Care Med. 2008 Sep;36(9):2651-9. doi: 10.1097/CCM.0b013e318183f646.

PMID:
18679119
21.

Functional (neurologic) recovery following transient focal cerebral ischemia in the rat requires at least 80% of ipsilateral cortical and subcortical integrity.

Haelewyn B, Rouillon C, Risso JJ, Abraini JH.

Exp Neurol. 2008 Sep;213(1):238-40. doi: 10.1016/j.expneurol.2008.05.012. Epub 2008 May 27.

PMID:
18599041
22.

Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.

Rouillon C, Abraini JH, David HN.

Exp Neurol. 2008 Jul;212(1):213-7. doi: 10.1016/j.expneurol.2008.04.002. Epub 2008 Apr 15.

PMID:
18501353
23.

Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.

Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.

Brain Res. 2008 Mar 10;1198:44-54. doi: 10.1016/j.brainres.2008.01.025. Epub 2008 Jan 18.

PMID:
18261716
24.

Modulation by the dorsal, but not the ventral, hippocampus of the expression of behavioural sensitization to amphetamine.

Degoulet M, Rouillon C, Rostain JC, David HN, Abraini JH.

Int J Neuropsychopharmacol. 2008 Jun;11(4):497-508. Epub 2007 Nov 30.

PMID:
18047756
25.

Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia.

David HN, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou G, Risso JJ, Lemaire M, Abraini JH.

FASEB J. 2008 Apr;22(4):1275-86. Epub 2007 Nov 16.

PMID:
18024836
27.

DNA polymerase switching on homotrimeric PCNA at the replication fork of the euryarchaea Pyrococcus abyssi.

Rouillon C, Henneke G, Flament D, Querellou J, Raffin JP.

J Mol Biol. 2007 Jun 1;369(2):343-55. Epub 2007 Mar 24.

PMID:
17442344
28.
29.

[Alveolar injuries in the upper incisor region in the child].

Pernice L, Gacon J, Fourestier J, Ribault JY, Roubaudi G, Rouillon C.

Rev Stomatol Chir Maxillofac. 1990;91 Suppl 1:71-2. French.

PMID:
2130467

Supplemental Content

Loading ...
Support Center